Two studies examined follistatin changes after the use of COCs containing 35 μg EE and 2 mg CPA in 73 PCOS patients [5, 18] and, in both studies, the follistatin levels were significantly increased (p <0.001 for both). This evidence concerns the gene FST and polycystic ovary syndrome.